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Dengue Virus
Serotype 3,
Karachi, Pakistan
To the Editor: The global preva-
lence of dengue fever (DF) has grown
dramatically in recent decades; DF is
now endemic to >100 countries (1).
Dengue hemorrhagic fever (DHF), a
potentially lethal complication of
dengue virus infection, was first rec-
ognized in Asia in the 1950s and is
now a leading cause of hospitalization
and death among children (1). During
the past decade, DHF epidemics have
occurred in China, Sri Lanka, India,
the Maldives, Bangladesh, and
Pakistan (2–4).
In Pakistan, an outbreak of DHF
was first reported in Karachi in 1994
(4). Through mid-2005, 15–20
patients with DF or DHF were admit-
ted each year to the Aga Khan
University Hospital (AKUH), a terti-
ary care referral center in Karachi.
Many more cases, however, may have
gone unrecognized. Ours is the first
report of dengue virus serotype 3 in
Pakistan.
From September through
December 2005, at least 3 major hos-
pitals in Karachi, including AKUH,
had a sudden increase in the number
of patients with signs consistent with
the World Health Organization defi-
nition of DHF: high fever, rash, epis-
taxis, gum bleeding, liver dysfunc-
tion, and thrombocytopenia (platelets
<100,000/mm3); most had evidence
of capillary leakage in the form of
raised hematocrit and pleural effusion
with or without ascites (5). Because
in Pakistan, Crimean-Congo hemor-
rhagic fever (CCHF) is an important
differential diagnosis for hemorrhag-
ic fever, most patients seen at AKUH
received care in strict isolation and
were empirically treated with rib-
avirin. At time of admission, blood
samples were collected for serologic
testing for dengue virus and reverse
transcription (RT)–PCR testing for
CCHF virus. The first 5 samples, col-
lected during the initial 2 weeks of
the outbreak, were also sent to the
Special Pathogens Reference Unit,
Centre for Emergency Preparedness
and Response, Health Protection
Agency, Salisbury, United Kingdom,
for diagnostic confirmation. In the
absence of a local surveillance and
disease notification system, the num-
ber of patients with suspected DHF at
different hospitals in Karachi could
not be ascertained.
Of the 106 patients who had a
clinical diagnosis compatible with
DHF (5), 9 (8.5%) died and 97
(91.5%) recovered. Patients with pos-
sible DF (fever, mild thrombocytope-
nia with platelets >100,000/mm3)
were not admitted and were treated as
outpatients. Dengue virus infection
was confirmed for 42 of the 106
patients. Serum samples from 39
patients contained anti–dengue virus
immunoglobulin M (IgM) antibody
(Chemicon, Temecula, CA, USA).
Diagnosis for 6 of these patients was
confirmed by using immunoblot tests
(Dengue IgM Blot and Dengue IgG
Blot, Genelabs Diagnostics,
Singapore). Of the 9 patients who
died, 6 had dengue IgM and IgG
according to immunoblot testing, and
3 had dengue IgM according to
ELISA. Diagnoses for 3 additional
patients were confirmed by RT-PCR.
An RT-PCR assay specific for
dengue viruses (6) was used to ampli-
fy the C/PrM/M region of the genome
and produced PCR products of the
expected size in 3 patient samples: 2
(K1 and 2) from Karachi and 1 (B)
from Balochistan. The PCR products
were sequenced, and data were subse-
quently placed in GenBank under
accession numbers DQ469827 for
D3418-05 (patient K1), DQ469828
for D3419-05 (patient K2), and
DQ469826 for D3417-05 (patient B).
These data were compared with those
in databases by using the basic local
alignment search tool for nucleotides
(blastn), with default settings (7). For
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each sequence analyzed, the lowest
Expect (E) value showed significant
similarity with a dengue serotype 3
isolate from India in 2004
(DQ323042). A phylogenetic tree was
constructed with a collection of
dengue sequences (online Appendix
Table, available from www.cdc.
gov/ncidod/EID/13/1/182-appT.htm).
Phylo-genetic relationships between
sequences are depicted in the Figure.
Sequences from the 2005 outbreak are
most similar to those from Indian
strains of dengue serotype 3, which
were isolated in Delhi.
An unexpected finding was the
detection, at both AKUH and the UK
Special Pathogens Reference Unit, of
dengue-3 and CCHF virus RNA in the
sample from patient B. CCHF is
endemic to the rural Balochistan
province of Pakistan, where DF has
been documented (8). In the absence
of information on the current dengue
situation in Balochistan and given the
increasing dengue activity in Karachi,
a similar increase can be assumed for
Balochistan. Possible introduction of
dengue serotype 3 in a CCHF-endem-
ic area resulted in dual infection in
patient B, who essentially had clinical
and laboratory features compatible
with DHF. Patient B received ribavirin
and recovered. Our results suggest that
the 2005 outbreak of DHF in Karachi,
Pakistan, was caused by strains of
dengue virus serotype 3 related to
those circulating in India (9). 
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Figure. Maximum-likelihood phylogenetic tree of established dengue virus 3 serotypes
and new sequences from Pakistan identified in this study. The tree is based on a 238-nt
sequence alignment comprising the C/PrM/M gene (nucleotides: 179–417 dengue virus 3
prototype [NC_001475]). The bar shows the number of substitutions per bases weighted
by the Tamura-Nei algorithm. Horizontal distances are equivalent to the distances
between isolates; numbers at nodes indicate support values for the branch of the tree
inferred at the node. The origins of the sequences used to reconstruct this tree are
detailed in the online Appendix Table.
